Ameenat Lola Solebo1, Isabelle Russell-Eggitt2, Phillippa M Cumberland3, Jugnoo S Rahi4. 1. Life Course Epidemiology and Biostatistics Section, University College London Institute of Child Health, London, UK NIHR Moorfields Biomedical Research Centre / Institute of Ophthalmology, University College London, London, UK Ulverscroft Vision Research Group, Institute of Child Health, University College London, London, UK. 2. Ulverscroft Vision Research Group, Institute of Child Health, University College London, London, UK Great Ormond Street Hospital for Children, London, UK. 3. Life Course Epidemiology and Biostatistics Section, University College London Institute of Child Health, London, UK Ulverscroft Vision Research Group, Institute of Child Health, University College London, London, UK. 4. Life Course Epidemiology and Biostatistics Section, University College London Institute of Child Health, London, UK NIHR Moorfields Biomedical Research Centre / Institute of Ophthalmology, University College London, London, UK Ulverscroft Vision Research Group, Institute of Child Health, University College London, London, UK Great Ormond Street Hospital for Children, London, UK.
Abstract
BACKGROUND/AIMS: To investigate outcomes following cataract surgery with and without primary intraocular lens (IoL) implantation in children under 2 years of age with congenital or infantile cataract. METHOD: Prospective population based cohort study undertaken through the British Isles Congenital Cataract Interest Group, with systematic data collection on children undergoing surgery in UK and Ireland between January 2009 and December 2010. ORs for the association between IoL implantation and visual acuity, postoperative glaucoma and reoperation at 1 year after surgery were estimated using multivariable regression analysis to control for potential confounders. RESULTS: Of 221 children, 56/131 with bilateral and 48/90 with unilateral cataract underwent primary IoL implantation. IoL implantation was independently associated with better visual outcome in bilateral (OR 4.6, 95% CI 1.6 to 13.1, p=0.004) but not unilateral disease. IoL use increased the odds of reoperation requiring repeat general anaesthetic (bilateral OR 5.5, p<0.01; unilateral OR 16.7, p<0.01). IoL implantation did not reduce the odds of postoperative glaucoma. CONCLUSIONS: The use of IoLs in cataract surgery in young children should be critically reassessed, particularly used in settings/communities where close, long-term follow-up is challenging. The absence of visual benefit and the lack of a previously postulated protective effect against postoperative glaucoma serve to question the value of IoLs in unilateral disease. The potential association between IoL use and better early visual outcomes in bilateral disease needs to be balanced against the risk of reoperation and exposure to additional general anaesthetics during a key period of neurodevelopment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
BACKGROUND/AIMS: To investigate outcomes following cataract surgery with and without primary intraocular lens (IoL) implantation in children under 2 years of age with congenital or infantile cataract. METHOD: Prospective population based cohort study undertaken through the British Isles Congenital Cataract Interest Group, with systematic data collection on children undergoing surgery in UK and Ireland between January 2009 and December 2010. ORs for the association between IoL implantation and visual acuity, postoperative glaucoma and reoperation at 1 year after surgery were estimated using multivariable regression analysis to control for potential confounders. RESULTS: Of 221 children, 56/131 with bilateral and 48/90 with unilateral cataract underwent primary IoL implantation. IoL implantation was independently associated with better visual outcome in bilateral (OR 4.6, 95% CI 1.6 to 13.1, p=0.004) but not unilateral disease. IoL use increased the odds of reoperation requiring repeat general anaesthetic (bilateral OR 5.5, p<0.01; unilateral OR 16.7, p<0.01). IoL implantation did not reduce the odds of postoperative glaucoma. CONCLUSIONS: The use of IoLs in cataract surgery in young children should be critically reassessed, particularly used in settings/communities where close, long-term follow-up is challenging. The absence of visual benefit and the lack of a previously postulated protective effect against postoperative glaucoma serve to question the value of IoLs in unilateral disease. The potential association between IoL use and better early visual outcomes in bilateral disease needs to be balanced against the risk of reoperation and exposure to additional general anaesthetics during a key period of neurodevelopment. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Entities:
Keywords:
Child health (paediatrics); Epidemiology; Lens and zonules; Treatment Surgery
Authors: Michael X Repka; Trevano W Dean; Elizabeth L Lazar; Kimberly G Yen; Phoebe D Lenhart; Sharon F Freedman; Denise Hug; Bahram Rahmani; Serena X Wang; Raymond T Kraker; David K Wallace Journal: Ophthalmology Date: 2016-10-18 Impact factor: 12.079
Authors: Sharon F Freedman; Raymond T Kraker; Michael X Repka; David K Wallace; Alejandra de Alba Campomanes; Tammy L Yanovitch; Faruk H Orge; Matthew D Gearinger Journal: JAMA Ophthalmol Date: 2020-01-01 Impact factor: 7.389